Seasonal Influenza Global Clinical Trials Review 2024 Featuring GSK, Novartis, Johnson & Johnson, Novavax, CSL, Sinovac Biotech, Moderna, and Sanofi, Among Others
05 avr. 2024 09h29 HE
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Seasonal Influenza - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
H1 Launches New Solution Empowering Doctors to Find Global Health Opportunities
04 avr. 2024 12h00 HE
|
H1
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- H1, the leading platform for global healthcare data with a database of 10M+ healthcare professional profiles, today announced a new module within its H1...
Glioblastoma Multiforme (GBM) Global Clinical Trials Review 2024, by Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
03 avr. 2024 11h27 HE
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical...
Lupus Nephritis Global Clinical Trials Review 2024
03 avr. 2024 11h13 HE
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Lupus Nephritis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
Molecure has published its financial report for 2023 - the company has significantly accelerated the development of its clinical and pre-clinical programmes and plans to make strong progress in research in 2024 and 2025
03 avr. 2024 04h00 HE
|
Molecure
Initiation of Phase II clinical trial of OATD-01 (KITE) for the treatment of pulmonary sarcoidosis following approval from the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare...
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Global Clinical Trials Review 2024, Featuring Takeda Pharmaceutical, JCR Pharmaceuticals, GC Corp, RegenxBio, Sangamo Therapeutics and Generium
02 avr. 2024 09h48 HE
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Mucopolysaccharidosis II (Mps II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024" clinical trials has been added to ...
Global AI-based Clinical Trial Solutions Market Projected to Reach $5.65 Billion by 2028
01 avr. 2024 18h04 HE
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "AI-based Clinical Trial Solution Providers Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Market Growth...
Clinical Trial Supplies Market Report 2024-2034 - Rising Demand for Biologics Propelling Growth of Cold Chain Distribution Supplies
29 mars 2024 05h20 HE
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.World revenue for the Clinical Trial...
Global Clinical Trial Supply & Logistics Market for Pharmaceutical Industry Poised for Growth, Reaching USD 6.9 Billion by 2028
27 mars 2024 13h13 HE
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Supply & Logistics for Pharmaceutical Industry Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown &...
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
26 mars 2024 10h25 HE
|
ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, March 27, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company...